Intelligent Bio Solutions Inc. (NASDAQ: INBS)

Intelligent Bio Solutions Inc., often recognized by its NASDAQ ticker symbol INBS, is a company that operates in the medical technology industry. Its primary business activities involve the development and commercialization of non-invasive diagnostic tests and screening solutions, with a global reach aimed at providing intelligent, pain-free, and accessible solutions to improve the quality of life.

The company's main offerings include the Intelligent Fingerprinting Platform and the Biosensor Platform. The Intelligent Fingerprinting Platform is a portable, handheld device that analyzes fingerprint sweat to detect drugs of abuse, including opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. This platform offers several advantages over traditional drug testing methods, as it is non-invasive, pain-free, and provides rapid results.